Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Muniz M, Loprinzi CL, Orme JJ, Koch RM, Mahmoud AM, Kase AM, Riaz IB, Andrews JR, Thorpe MP, Johnson GB, Kendi AT, Kwon ED, Nauseef JT, Morgans AK, Sartor O, Childs DS.
Muniz M, et al. Among authors: andrews jr.
Cancer Treat Rev. 2024 Apr 30;127:102748. doi: 10.1016/j.ctrv.2024.102748. Online ahead of print.
Cancer Treat Rev. 2024.
PMID: 38703593
Review.